Cardiogenesis Transmyocardial Revascularization Registry

CompletedOBSERVATIONAL
Enrollment

203

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

April 30, 2015

Study Completion Date

June 30, 2015

Conditions
Class IV Angina
Trial Locations (24)

10075

The Feinstein Institute for Medical Research, New York

32174

Coastal Cardiovascular and Thoracic Associates, PA, Ormond Beach

32207

Cardiothoracic and Vascular Surgical Associates, Jacksonville

33316

Broward Health Medical Center, Fort Lauderdale

33435

Bethesda Memorial Hospital, Boynton Beach

37203

Tristar Cardiovascular Surgery, Nashville

37923

East Tennessee Cardiovascular Surgery Group, Knoxville

40503

Lexington Cardiac Research Foundation, Inc., Lexington

42003

Regional Heart & Lung Surgery, Paducah

42303

Owensboro Health, Inc., Owensboro

64111

Saint Luke's Hospital, Kansas City

73120

Oklahoma Heart Hospital, Oklahoma City

75230

Cardiopulmonary Research Science and Technology Institute, Dallas

85722

University of Arizona, Tuscon

90017

Advanced Cardiothoracic Surgery Medical Group, Los Angeles

91204

Hurwitz & Roberts Med Corp, Glendale

91325

Soltero & Yasuda Associates Cardiothoracic & Vascular Medical Group, Northridge

92270

Joseph W. Wilson, MD, Inc., Rancho Mirage

92708

The Vo Group, Fountain Valley

93030

Cardiovascular & Thoracic Surgeons of Ventura County, APC, Oxnard

93301

California Cardiac Surgeons, Bakersfield

95819

Sutter Institute for Medical Research, Sacramento

30912-

Georgia Health Sciences University Research Institute, Inc., Augusta

07601

Hackensack University Medical Center, Hackensack

All Listed Sponsors
lead

Cardiogenesis Corporation, a wholly-owned subsidiary of CryoLife, Inc.

INDUSTRY

NCT01827319 - Cardiogenesis Transmyocardial Revascularization Registry | Biotech Hunter | Biotech Hunter